wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26745948-76A9105B-78DD-4AE3-BF2A-18741DA9F2F3
Q26745948-76A9105B-78DD-4AE3-BF2A-18741DA9F2F3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26745948-76A9105B-78DD-4AE3-BF2A-18741DA9F2F3
New drugs in prostate cancer
P2860
Q26745948-76A9105B-78DD-4AE3-BF2A-18741DA9F2F3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26745948-76A9105B-78DD-4AE3-BF2A-18741DA9F2F3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8f0d18e1b9fecd091e6917aa71cec22747ec793e
P2860
Phase II randomized, double-blind, placebo-controlled study of tasquinimod in men with minimally symptomatic metastatic castrate-resistant prostate cancer.